期刊文献+

miR-572在胃癌组织中的表达 被引量:2

Expression of miR- 572 in gastric carcinoma
下载PDF
导出
摘要 目的观察miR-572在胃癌及配对正常胃组织中的表达情况及差异性。方法利用实时荧光定量PCR技术检测26例胃癌组织及其正常胃黏膜组织中miR-572的表达,并分析其与临床病理资料的关系。结果与配对正常胃黏膜组织比较,miR-572在14例胃癌组织中呈高表达,在12例胃癌组织中呈低表达。miR-572在胃癌组织中的表达均高于正常胃黏膜组织(P<0.05);胃癌组织中不同年龄、性别、临床分期、组织学类型、分化程度和有无淋巴结转移之间miR-572的表达差异无统计学意义(P>0.05);而胃癌组织中腺癌、低分化、低分期和淋巴结转移者miR-572呈高表达的趋势。结论 miR-572在胃癌组织中高表达,可能与胃癌发生发展有关,但其临床病理学意义和具体作用机制有待进一步探讨。 Objective To probe the expression and differences of miR -572 in gastric carcinoma and matched normal gastric tissues.Methods The expression of miR572 in 26 biopsies were tested by using real -time quantitative PCR and then to analyze the relationship between the expression and the clinic opathological data .Results Compared with matched normal gastric tissue , the miR-572 showed a high expression in 14 cases of gastric carcinoma and a low ex-pression in 12 cases of gastric carcinoma .The expression of miR-572 in gastric carcinoma are higher than normal mucosa (P〈0.05).There are no significant differences between/among ages, genders, clinical stages, histological types, de-grees of differentiation and lymph node metastasis or not (P〉0.05).However there is a trend that miR -572 expressed highly in adenocarcinoma , poorly differentiated , low stage and metastasis groups .Conclusion miR-572 is highly ex-pressed in gastric cancer may be related to the occurrence and development of gastric cancer ; but its clinicopathological significance and specific mechanism should be further explored .
出处 《广东医学》 CAS CSCD 北大核心 2014年第9期1338-1341,共4页 Guangdong Medical Journal
基金 国家自然科学基金资助项目(编号:81071989 81272760) 广东省自然科学基金资助项目(编号:S2011010004178) 广东省科技计划项目(编号:2012B060300019)
关键词 miR-572 胃癌 实时荧光定量PCR miR-572 gastric cancer qRT- PCR
  • 相关文献

参考文献15

  • 1VOLINIA S, CALIN G A, LIU C G, et al. A mieroRNA expression signature of human solid tumors defines cancer gene targets [J].Proc Natl Acad Sci U S A, 2006, 103(7) : 2257 -2261.
  • 2LEWIS B P, BURGE C B, BARTEL D P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets[J]. Cell, 2005, 120( 1 ) : 15 -20.
  • 3GUO J, MIAO Y, XIAO B, et al. Differential expression of microRNA species in human gastric cancer versus non - tumorous tissues [J]. J Gastroenterol Hepatol, 2009, 24 (4) : 652 - 657.
  • 4WANG Y, LEE C G. MicroRNA and cancer focus on apoptosis[J]. JCellMolMed, 2009, 13(1): 12 -23.
  • 5ZHU D X, ZHU W, FANG C, et al. miR - 181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti - apoptosis genes [ J ]. 2012, 33(7) : 1294 -1301.
  • 6SIEGEL S R, MACKENZIE J, CHAPLIN G, et microRNAs involved in multiple sclerosis [ J ]. 2012, 39(5) : 6219 -6225.
  • 7Carcinogenesis al. Circulating Mol Biol Rep, FULCI V, CHIARETU S, GOLDONI M, et al. Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia[J]. Blood, 2007, 109( 11 ) : 4944 -4951.
  • 8MENG F, HENSON R, WEHBE JANEK H, et al. MicroRNA - 21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer[ J ]. Gastroenterology, 2007, 133 (2) : 647 - 658.
  • 9YAN L X, HUANG X F, SHAO Q, et al. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis [J]. RNA, 2008, 14(11): 2348-2360.
  • 10ZHANG Z, LI Z, GAO C, et al. miR -21 plays a pivotal role in gastric cancer pathogenesis and progression [ J ]. Lab Invest, 2008, 88(12) : 1358 - 1366.

二级参考文献29

  • 1Iorio MV,Ferracin M,Liu CG,Veronese A,Spizzo R,Sabbioni S,Magri E,Pedriali M,Fabbri M,Campiglio M,Menard S,Palazzo JP,Rosenberg A,Musiani P,Volinia S,Nenci I,Calin GA,Querzoli P,Negrini M,Croce CM.MicroRNA gene expression deregulation in human breast cancer.Cancer Res 2005; 65:7065-7070.
  • 2He H,Jazdzewski K,Li W,Liyanarachchi S,Nagy R,Volinia S,Calin GA,Liu CG,Franssila K,Suster S,Kloos RT,Croce CM,de la Chapelle A.The role of microRNA genes in papillary thyroid carcinoma.Proc Natl Acad Sci U S A 2005; 102:19075-19080.
  • 3Chan JA,Krichevsky AM,Kosik KS.MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.Cancer Res 2005; 65:6029-6033.
  • 4Bandres E,Cubedo E,Agirre X,Malumbres R,Zarate R,Ramirez N,Abajo A,Navarro A,Moreno I,Monzó M,García-Foncillas J.Identification by Realtime PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues.Mol Cancer 2006; 5:29.
  • 5Szafranska AE,Davison TS,John J,Cannon T,Sipos B,Maghnouj A,Labourier E,Hahn SA.MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma.Oncogene 2007; 26:4442-4452.
  • 6Lin SL,Chiang A,Chang D,Ying SY.Loss of mir-146a function in hormone-refractory prostate cancer.RNA 2008; 14:417-424.
  • 7Murakami Y,Yasuda T,Saigo K,Urashima T,Toyoda H,Okanoue T,Shimotohno K.Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and nontumorous tissues.Oncogene 2006; 25:2537-2545.
  • 8Jiang J,Gusev Y,Aderca I,Mettler TA,Nagorney DM,Brackett DJ,Roberts LR,Schmittgen TD.Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection,cirrhosis,and patient survival.Clin Cancer Res 2008;14:419-427.
  • 9Huang YS,Dai Y,Yu XF,Bao SY,Yin YB,Tang M,Hu CX.Microarray analysis of microRNA expression in hepatocellular carcinoma and non-tumorous tissues without viral hepatitis.J Gastroenterol Hepatol 2008; 23:87-94.
  • 10Budhu A,Jia HL,Forgues M,Liu CG,Goldstein D,Lam A,Zanetti KA,Ye QH,Qin LX,Croce CM,Tang ZY,Wang XW.Identification of metastasisrelated microRNAs in hepatocellular carcinoma.Hepatology 2008; 47:897-907.

共引文献25

同被引文献13

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部